SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-189503
Filing Date
2024-07-31
Accepted
2024-07-31 07:55:32
Documents
5
Effectiveness Date
2024-07-31

Document Format Files

Seq Description Document Type Size
1 S-8 d814741ds8.htm S-8 38952
2 EX-5.1 d814741dex51.htm EX-5.1 6524
3 EX-23.1 d814741dex231.htm EX-23.1 1600
4 EX-FILING FEES d814741dexfilingfees.htm EX-FILING FEES 13426
5 GRAPHIC g814741g42y53.jpg GRAPHIC 3019
  Complete submission text file 0001193125-24-189503.txt   65830
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281119 | Film No.: 241159925
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)